Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.
In 2018 the average number of employees was 50’370. The net sales amounted to approximately 17’498 mio €. Research and development was supported with 3’164 mio € corresponding to 18 % of the net sales.
Boehringer Ingelheim Pharma GmbH & Co KG
Binger Str. 173
55218 Ingelheim am Rhein
Tel: +49 6132 77 98552